Pfizer Buys Allergan in $160B Deal That Will Slash Its U.S. Taxes

Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world’s largest drug maker. It’s also the largest so-called inversion, where an American corporation combines with a company headquartered in a country with a lower corporate tax rate, saving [...]